# Tevogen Inc.: filings

TVGN · Nasdaq · CIK 1860871 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tvgn.md) · [Financials](/companies/tvgn/financials.md) · [Filings](/companies/tvgn/filings.md) · [Insiders](/companies/tvgn/insiders.md)

## Reports and events: 100 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 49, 8-K 48, 3 26, 424B3 22, CORRESP 16, 10-Q 15, UPLOAD 13, 425 10, SC 13G 9, SC 13G/A 8, 8-K/A 6, EFFECT 6, S-1/A 6, 10-K 5, DEF 14A 5, NT 10-Q 5, SCHEDULE 13D/A 5, NT 10-K 4, PRE 14A 4, S-8 4, SC 13D 4, 144 3, DEFA14A 3, PRER14A 3, S-4/A 3, 3/A 2, 8-A12B 2, CERT 2, S-1 2, S-3 2, SC 13D/A 2, 10-K/A 1, 10-Q/A 1, 25-NSE 1, 424B4 1, 424B5 1, 4/A 1, DEFR14A 1, DRS 1, DRS/A 1, POS AM 1, S-4 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-30 | 16:40 ET | [8-K](/filings/0001493152-26-045123.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-045123 |
| 2026-09-16 | 20:07 ET | [SCHEDULE 13D/A](/filings/0001123292-26-001317.md) | Ownership report, active investor, amended | 0001123292-26-001317 |
| 2026-09-16 | 20:04 ET | [SCHEDULE 13D/A](/filings/0001123292-26-001316.md) | Ownership report, active investor, amended | 0001123292-26-001316 |
| 2026-09-16 | 17:12 ET | [8-K](/filings/0001493152-26-042952.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-042952 |
| 2026-09-10 | 09:19 ET | [8-K](/filings/0001493152-26-042095.md) | 8.01 Other events | 0001493152-26-042095 |
| 2026-08-26 | 15:10 ET | [8-K](/filings/0001493152-26-040216.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-040216 |
| 2026-08-14 | 17:16 ET | [10-Q](/filings/0001493152-26-038509.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038509 |
| 2026-08-03 | 09:20 ET | [DEF 14A](/filings/0001493152-26-035757.md) | Proxy statement, period 2026-08-03 | 0001493152-26-035757 |
| 2026-07-30 | 08:31 ET | [8-K](/filings/0001493152-26-035334.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-035334 |
| 2026-07-14 | 21:56 ET | [SCHEDULE 13D/A](/filings/0001123292-26-001010.md) | Ownership report, active investor, amended | 0001123292-26-001010 |
| 2026-05-15 | 17:01 ET | [10-Q](/filings/0001493152-26-023920.md) | Quarterly report, period 2026-03-31 | 0001493152-26-023920 |
| 2026-04-30 | 17:00 ET | [10-K/A](/filings/0001493152-26-020704.md) | Annual report, amended, period 2025-12-31 | 0001493152-26-020704 |
| 2026-04-22 | 17:15 ET | [8-K](/filings/0001493152-26-018590.md) | 3.01 Delisting notice | 0001493152-26-018590 |
| 2026-03-31 | 17:16 ET | [10-K](/filings/0001493152-26-014326.md) | Annual report, period 2025-12-31 | 0001493152-26-014326 |
| 2026-03-25 | 17:04 ET | [8-K](/filings/0001493152-26-012701.md) | 8.01 Other events | 0001493152-26-012701 |
| 2026-03-04 | 09:04 ET | [8-K](/filings/0001493152-26-008786.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008786 |
| 2026-02-25 | 17:00 ET | [8-K](/filings/0001493152-26-008065.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-008065 |
| 2026-01-30 | 15:37 ET | [8-K](/filings/0001493152-26-004461.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-004461 |
| 2026-01-26 | 17:29 ET | [DEF 14A](/filings/0001493152-26-003649.md) | Proxy statement, period 2026-01-26 | 0001493152-26-003649 |
| 2025-12-16 | 20:47 ET | [SCHEDULE 13D/A](/filings/0001123292-25-000761.md) | Ownership report, active investor, amended | 0001123292-25-000761 |
| 2025-11-14 | 09:22 ET | [10-Q](/filings/0001493152-25-022641.md) | Quarterly report, period 2025-09-30 | 0001493152-25-022641 |
| 2025-09-26 | 17:15 ET | [8-K](/filings/0001493152-25-015784.md) | 3.01 Delisting notice | 0001493152-25-015784 |
| 2025-08-14 | 16:45 ET | [10-Q](/filings/0001641172-25-024101.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024101 |
| 2025-07-25 | 19:48 ET | [SCHEDULE 13D/A](/filings/0001641172-25-021070.md) | Ownership report, active investor, amended | 0001641172-25-021070 |
| 2025-07-10 | 09:15 ET | [8-K](/filings/0001641172-25-018533.md) | 8.01 Other events | 0001641172-25-018533 |
| 2025-07-03 | 17:25 ET | [8-K](/filings/0001641172-25-017873.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-017873 |
| 2025-06-30 | 17:21 ET | [8-K](/filings/0001641172-25-017198.md) | 8.01 Other events | 0001641172-25-017198 |
| 2025-06-23 | 17:06 ET | [8-K](/filings/0001641172-25-016126.md) | 5.07 Shareholder vote results | 0001641172-25-016126 |
| 2025-06-03 | 13:46 ET | [8-K](/filings/0001641172-25-013396.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-013396 |
| 2025-05-14 | 17:27 ET | [10-Q](/filings/0001641172-25-010395.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010395 |
| 2025-04-30 | 17:04 ET | [DEF 14A](/filings/0001641172-25-007871.md) | Proxy statement, period 2025-04-30 | 0001641172-25-007871 |
| 2025-04-25 | 16:33 ET | [8-K](/filings/0001641172-25-006227.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-006227 |
| 2025-04-17 | 16:15 ET | [8-K](/filings/0001641172-25-005236.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-005236 |
| 2025-04-02 | 17:19 ET | [10-K](/filings/0001641172-25-002426.md) | Annual report, period 2024-12-31 | 0001641172-25-002426 |
| 2025-01-28 | 16:51 ET | [8-K](/filings/0001493152-25-004002.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-004002 |
| 2024-11-19 | 16:38 ET | [10-Q](/filings/0001493152-24-046839.md) | Quarterly report, period 2024-09-30 | 0001493152-24-046839 |
| 2024-08-26 | 16:05 ET | [8-K/A](/filings/0001493152-24-033873.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity | 0001493152-24-033873 |
| 2024-08-23 | 17:02 ET | [8-K](/filings/0001493152-24-033756.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-24-033756 |
| 2024-08-14 | 16:38 ET | [10-Q](/filings/0001493152-24-032294.md) | Quarterly report, period 2024-06-30 | 0001493152-24-032294 |
| 2024-08-01 | 20:45 ET | [S-1/A](/filings/0001493152-24-029808.md) | Registration statement, amended | 0001493152-24-029808 |
| 2024-07-23 | 17:13 ET | [S-1/A](/filings/0001493152-24-028834.md) | Registration statement, amended | 0001493152-24-028834 |
| 2024-06-21 | 17:14 ET | [S-1](/filings/0001493152-24-024790.md) | Registration statement | 0001493152-24-024790 |
| 2024-06-21 | 16:15 ET | [8-K](/filings/0001493152-24-024727.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-24-024727 |
| 2024-06-11 | 16:30 ET | [8-K](/filings/0001493152-24-023483.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-023483 |
| 2024-05-30 | 16:30 ET | [8-K/A](/filings/0001493152-24-021990.md) | 9.01 Financial statements and exhibits | 0001493152-24-021990 |
| 2024-05-28 | 17:22 ET | [10-Q](/filings/0001493152-24-021650.md) | Quarterly report, period 2024-03-31 | 0001493152-24-021650 |
| 2024-05-16 | 16:52 ET | [8-K](/filings/0001493152-24-020275.md) | 1.01 Entry into a material agreement | 0001493152-24-020275 |
| 2024-05-02 | 17:25 ET | [8-K](/filings/0001493152-24-017597.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-017597 |
| 2024-04-29 | 21:22 ET | [8-K/A](/filings/0001493152-24-016797.md) | 9.01 Financial statements and exhibits | 0001493152-24-016797 |
| 2024-04-29 | 21:21 ET | [10-K](/filings/0001493152-24-016796.md) | Annual report, period 2023-12-31 | 0001493152-24-016796 |

Page 1 of 2. [Older](/companies/tvgn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.